# Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

> clinical trial · VERIFIED · 2026-07-06

Status: COMPLETED · Sponsor: Seagen, a wholly owned subsidiary of Pfizer · Condition: Melanoma

- Company: Seagen, a wholly owned subsidiary of Pfizer
- Sector: Melanoma
- Primary source: https://clinicaltrials.gov/study/NCT04609566

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.